Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Technical Problems and Ethical Concerns Regarding Gene Editing in Human Germlines and Embryos

Editorial

Author
Mohammad Reza Sadeghi
Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
10.18502/jri.v24i3.13270
  1. European society of human reproduction and embryology [Internet]. Belgium: European society of human reproduc-tion and embryology: Focus on reproduction At least 12 million babies’ since the first IVF birth in 1978; 2023 Jun 28 [Ccited 2023 Jul 29]; [about 2 screens]. Availble from: https://www.focusonreproduction.eu/article/ESHRE-News-COP23_adamson
  2. Greco E, Litwicka K, Minasi MG, Cursio E, Greco PF, Barillari P. Preimplantation genetic testing: where we are today. Inte J Mol Sci. 2020;21(12):4381.
  3. Secord E, Hartog NL. Review of treatment for adenosine deaminase deficiency (ADA) severe combined immuno-deficiency (SCID). Ther Clin Risk Manag. 2022;18:939-44.
  4. Farhud DD, Zarif-Yeganeh M. CRISPR pioneers win 2020 nobel prize for chemistry. Iran J Public Health. 2020;49(12):2235-9.
  5. Gostimskaya I. CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing. Biochemistry (Moscow). 2022;87(8):777-88.
  6. Kubikova N, Esbert M, Titus S, Coudereau C, Savash M, Fagan J, et al. O-075 Deficiency of DNA double-strand break repair in human preimplantation embryos revealed by CRISPR-Cas9. Hum Reprod. 2023;38(Supplement_1):dead093-089.
Journal of Reproduction & Infertility
Volume 24, Issue 3
Summer 2023
Pages 145-146